Wei Ma from Durham, NC

Medicine Doctors

Wei W. Ma

view source

Specialties:

Neurology, Epileptologist

Work:

John F Kennedy Neuroscience Institute
65 James St, Edison, NJ 08820
(732)3217010 (phone), (732)6321584 (fax)

Education:

Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1983

Procedures:

Hearing Evaluation
Lumbar Puncture
Neurological Testing
Sleep and EEG Testing

Conditions:

Alzheimer's Disease
Anemia
Anxiety Phobic Disorders
Attention Deficit Disorder (ADD)
Autism

Languages:

Chinese
English
Russian
Spanish

Description:

Dr. Ma graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1983. She works in Edison, NJ and specializes in Neurology and Epileptologist. Dr. Ma is affiliated with John F Kennedy Medical Center.

Resumes

Senior Scientist

view source

Location:

Raleigh, NC

Industry:

Pharmaceuticals

Work:

Catalent Pharma Solutions
Senior Scientist
Pharmacore 2010 - 2013
Research Scientist
Pamlico Pharmaceutical Inc 2009 - 2010
Senior Research Investigator
Serenex 2004 - 2008
Research Investigator
Cardinal Health 2002 - 2004
Scientist Ii

Education:

Rutgers University 1994 - 2000
Master of Science, Doctorates, Masters, Doctor of Philosophy, Organic Chemistry Jilin University
Bachelors, Bachelor of Science, Chemistry

Certifications:

“Sas Global Certificate-Base Programmer”

Software Manager

view source

Industry:

Semiconductors

Work:

Aviza Technology
Software Manager

Wei Ma

view source

Wei Ma

view source

Location:

United States

License Records

Wei Li Ma

Phone:

(401)7873118 (Work)

License #:

FMC02228 - Active

Category:

Food Safety

Issued Date:

Apr 11, 1995

Expiration Date:

Jan 31, 2019

Type:

Certified Food Safety Mgr

Us Patents

Quinazoline Derivatives For The Treatment Of Cancer
view source
US Patent:

7678803, Mar 16, 2010
Filed:

Aug 24, 2007
Appl. No.:

11/844584
Inventors:

Kenneth He Huang - Chapel Hill NC, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
Emilie D. Smith - Apex NC, US
Wei Ma - Cary NC, US
Andy Ommen - Durham NC, US
Assignee:

Serenex, Inc. - Durham NC
International Classification:

A61K 31/517
US Classification:

5142662, 544292, 5483625, 548510
Abstract:

The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I.

Purine, Pyrimidine, And Azaindole Derivatives
view source
US Patent:

20080070933, Mar 20, 2008
Filed:

Aug 24, 2007
Appl. No.:

11/844863
Inventors:

Kenneth Huang - Chapel Hill NC, US
James Veal - Apex NC, US
Emilie Smith - Apex NC, US
Wei Ma - Cary NC, US
International Classification:

C07D 473/00
A61K 31/416
A61K 31/52
A61P 31/00
A61P 35/00
C07D 231/54
US Classification:

514263200, 514263400, 514406000, 544277000, 548360100
Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula I, wherein A, R, X, X, X, Y, and n are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

Benzene, Pyridine, And Pyridazine Derivatives
view source
US Patent:

20080076813, Mar 27, 2008
Filed:

Aug 24, 2007
Appl. No.:

11/844704
Inventors:

Kenneth Huang - Chapel Hill NC, US
Philip Hughes - Chapel Hill NC, US
Wei Ma - Cary NC, US
Andy Ommen - Durham NC, US
Angela Woodward - Durham NC, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
International Classification:

A61K 31/403
A61K 31/277
A61K 31/4184
A61P 19/02
A61P 25/00
A61P 29/00
A61P 31/00
A61P 35/00
A61P 37/00
A61P 9/00
C07C 255/58
C07D 207/36
C07D 235/26
C07D 405/02
US Classification:

514387000, 514414000, 514421000, 514646000, 548302700, 548465000, 548512000, 558418000
Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein A, Q, Q, Q, R, and Rare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

Tetrahydroindole And Tetrahydroindazole Derivatives
view source
US Patent:

20080269193, Oct 30, 2008
Filed:

Apr 14, 2008
Appl. No.:

12/102128
Inventors:

Kenneth He Huang - Chapel Hill NC, US
Andy J. Ommen - Durham NC, US
Thomas E. Barta - Carrboro NC, US
Philip F. Hughes - Chapel Hill NC, US
James Veal - Apex NC, US
Wei Ma - Cary NC, US
Emilie D. Smith - Apex NC, US
Angela R. Woodward - Durham NC, US
W. Stephen McCall - Raleigh NC, US
International Classification:

A61K 31/55
A61K 31/404
C07D 405/12
A61K 31/416
A61P 35/00
C07D 231/54
C07D 403/14
US Classification:

51421203, 548465, 514414, 514406, 5483601, 540524
Abstract:

The invention provides indole and indazole compounds of Formula (I)or pharmaceutically acceptable salts thereof which are useful for treating and/or preventing diseases and/or disorders ameliorated by the inhibition of Heat-Shock Protein 90. The invention further provides pharmaceutical compositions comprising compounds of Formula (I) and methods of preparing compounds of Formula (I).